Ftse Mib
35.159,56
0,99%
DAX
18.716,42
-0,12%
S&P 500
5.246,68
0,48%
NASDAQ
16.510,31
0,74%
Bitcoin
61.584,20
-2,10%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Homology Medicines Inc (FIXX) Homology Medicines Inc (FIXX) Notizie

Homology Medicines Inc

FIXX
0,9347
0,00 (0,00%)
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/3/202421:30GLOBEHomology Medicines Declares Distribution to Common..
11/3/202412:37EDGAR2Form 425 - Prospectuses and communications, business..
11/3/202412:32EDGAR2Form 8-K - Current report
21/2/202422:04EDGAR2Form 425 - Prospectuses and communications, business..
15/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
13/2/202416:11EDGAR2Form S-4/A - Registration of securities, business..
05/1/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:29EDGAR2Form 425 - Prospectuses and communications, business..
03/1/202422:26EDGAR2Form 8-K - Current report
03/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:08GLOBEHomology Medicines Receives NASDAQ Notification Regarding..
17/11/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/11/202322:19EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202322:16EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202322:13EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202313:46EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202313:45EDGAR2Form 8-K - Current report
16/11/202313:17EDGAR2Form 425 - Prospectuses and communications, business..
16/11/202313:16EDGAR2Form 8-K - Current report
16/11/202313:05PRNUSQ32 Bio and Homology Medicines Announce Merger Agreement
14/11/202322:33GLOBEHomology Medicines Reports Third Quarter 2023 Financial..
10/10/202323:22EDGAR2Form 8-K - Current report
08/9/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:05GLOBEHomology Medicines Reports Second Quarter 2023 Financial..
14/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202303:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202323:29EDGAR2Form 8-K - Current report
27/7/202322:05GLOBEHomology Medicines Announces Plan to Evaluate Strategic..
27/7/202322:01GLOBEHomology Medicines Announces Encouraging Initial Data from..
16/5/202314:00GLOBEHomology Medicines Announces First Data from IND-Enabling..
Apertura: Min: Max:
Chiusura: 0,9347

La tua Cronologia

NASDAQ
FIXX
Homology Medicines
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network